Healthcare entity
All 2 tracked stories fall under one category: regulation. Walgreens Boots Alliance is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. Source depth averages 2 original sources per story, versus 5.1 across the same-window beat baseline.
Last mentioned: Jul 25, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 50 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 2 tracked stories fall under one category: regulation. Walgreens Boots Alliance is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. Source depth averages 2 original sources per story, versus 5.1 across the same-window beat baseline. Across a 124-day span, the pace is roughly 0.1 stories per week. Their average consequence score of 7 runs above the beat's 6.4 for that window. We currently track 2 Healthcare stories that mention CVS Health, published between March 24, 2026 and July 25, 2026.
Computed from the 2 stories linked to this entity, with beat comparisons drawn from all 291 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering CVS Health. Shared-story counts are live from our verified record — not editorial picks.
Supreme Court Ruling
SCOTUS maintains access to mifepristone by dismissing a challenge to FDA's rules on procedural grounds.
Pharmacy Certification
FDA updates REMS to allow retail pharmacies to dispense mifepristone upon certification.
Mail-Order Authorization
FDA permanently removes the requirement for in-person dispensing, allowing for telehealth and mail delivery.
Protocol Expansion
FDA extends usage window to 10 weeks and reduces required office visits from three to one.
Initial FDA Approval
FDA approves mifepristone for medical termination of pregnancy through seven weeks.
The legal reinstatement of Tylenol-autism lawsuits pressures healthcare providers to reconcile conflicting evidence on acetaminophen safety in pregnancy, potentially altering clinical guidance, patient counseling, and EHR decision support.
Medication abortion now accounts for the majority of pregnancy terminations in the United States, driven by the expansion of telehealth and mail-order pharmacy access. This shift has sparked a sophisticated regulatory counter-offensive from opponents targeting FDA-approved protocols and cross-state digital health providers.
CVS Health is linked from 2 stories on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
